Research, Innovation, and Policy: An Alliance Combating Antimicrobial Resistance.
The surge in antimicrobial resistance (AMR) has created a crisis that has become top priority for public health and global policy. Researchers, developers, innovators, funders, and policymakers need to curb AMR's rising trend by acting synergistically, boosting investment in developing solutions. This science-policy interface is now taking shape.